Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF837 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ZNF846 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | ZNF852 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ZNF865 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | ZNF91 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |